Gene: CPD
Official Full Name: carboxypeptidase Dprovided by HGNC
Gene Summary: The metallocarboxypeptidase family of enzymes is divided into 2 subfamilies based on sequence similarities. The pancreatic carboxypeptidase-like and the regulatory B-type carboxypeptidase subfamilies. Carboxypeptidase D has been identified as a regulatory B-type carboxypeptidase. CPD is a homolog of duck gp180, a hepatitis B virus-binding protein. Transcript variants utilizing alternative polyadenylation signals exist for this gene. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO06844 | CPD Knockout cell line (HeLa) | Human | CPD | 1:3~1:6 | Negative | Online Inquiry |
KO06845 | CPD Knockout cell line (HCT 116) | Human | CPD | 1:2~1:4 | Negative | Online Inquiry |
KO06846 | CPD Knockout cell line (HEK293) | Human | CPD | 1:3~1:6 | Negative | Online Inquiry |
KO06847 | CPD Knockout cell line (A549) | Human | CPD | 1:3~1:4 | Negative | Online Inquiry |
CPD Gene Knockout Cell Lines are genetically engineered cell models specifically designed to elucidate the function of the CPD (cytidine monophosphate deaminase) gene. These cell lines are generated through sophisticated CRISPR-Cas9 technology, which allows for precise gene editing and the creation of knockout models that lack the CPD gene expression. This innovative approach not only enables researchers to study gene function in a controlled environment but also facilitates a deeper understanding of the metabolic pathways influenced by CPD, particularly those related to nucleotide metabolism and cellular proliferation.
The CPD gene plays a pivotal role in the conversion of cytidine to uridine, influencing several cellular processes such as RNA synthesis and cell replication. By utilizing these knockout cell lines, scientists can investigate the perturbations in these pathways, providing insights into various biological phenomena, including cancer biology, metabolic disorders, and the effects of certain pharmacological agents. In a clinical or research setting, the ability to observe the phenotypic changes induced by the absence of the CPD gene opens new avenues for therapeutic exploration and biomarker identification.
What sets CPD Gene Knockout Cell Lines apart from traditional cell lines is their specificity and the advancement in gene editing technology. This specificity allows for targeted research without the confounding variables often seen with other methods, leading to more reliable and reproducible results. Furthermore, these cell lines can significantly reduce time and resource expenditure during the experimental phase compared to less precise models.
For researchers and clinicians, the value of CPD Gene Knockout Cell Lines lies in their capability to provide definitive answers regarding gene functionality and its implications in human health and disease. Leveraging these models allows for an accelerated understanding of critical biological processes and the potential for significant advancements in therapeutic strategies.
Our company is committed to excellence in offering cutting-edge genetic tools and cell models that empower scientific discovery. With a dedicated team of experts in molecular biology and genetic engineering, we ensure that our products meet the highest standards of quality and reliability, supporting the important work of researchers and clinicians around the globe.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.